Stage is a prognostic factor for surgically treated patients with early-stage lip cancer for whom a 'wait and see' policy in terms of neck status has been implemented

J Laryngol Otol. 2017 Oct;131(10):889-894. doi: 10.1017/S0022215117001669. Epub 2017 Aug 15.

Abstract

Objectives: To determine the locoregional control and survival rates (in terms of risk factors) of patients who underwent surgical resection of early-stage lip cancer and for whom a 'wait and see' policy in terms of neck status had been implemented.

Methods: The sociodemographic data, tumour stage, tumour characteristics and histopathological features of 41 patients with early-stage lip cancer were evaluated. Factors predictive of survival and locoregional recurrence were analysed. The five-year overall survival and disease-free survival rates were determined, and the prognostic risk factors were compared.

Results: The mean follow-up period was 60.5 months (range, 4-92 months). Age, sex, tumour stage, tumour thickness and volume, and perineural involvement were not predictive of locoregional recurrence or survival. Pathological tumour stage (T1 vs T2) was a prognostic factor for both five-year overall survival (87.3 vs 65.6 per cent, p = 0.042) and disease-free survival (88.6 vs 65.6 per cent, p = 0.037).

Conclusion: Tumour stage was clearly a major factor affecting the prognosis of surgically treated patients with early-stage lip cancer for whom a 'wait and see' policy in terms of neck status had been implemented.

Keywords: Squamous Cell; Carcinoma; Disease-Free Survival; Head And Neck Neoplasms; Lip Neoplasms; Local Neoplasm Recurrence; Prognosis; Survival.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Disease-Free Survival
  • Female
  • Humans
  • Lip Neoplasms / pathology
  • Lip Neoplasms / surgery*
  • Male
  • Middle Aged
  • Neck / pathology*
  • Neck / surgery
  • Neck Dissection / methods*
  • Neoplasm Staging
  • Prognosis
  • Survival Analysis
  • Treatment Outcome